ermeza
Pharmaranks rates Ermeza 3.3/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Ermeza (Levothyroxine Sodium) is a l-thyroxine used to treat Goiter, Myxedema, Thyroid Neoplasms, Autoimmune Thyroiditis.
Levothyroxine Sodium · by Mylan
Available as a generic: Levothyroxine Sodium
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Levothyroxine Sodium
- Drug class
- L-Thyroxine
- Form
- Solution
- Strength
- Levothyroxine Sodium 150MCG/5ML
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- May treat
- goiter, myxedema, thyroid neoplasms
- Manufacturer
- Mylan
- Half-life
- about 6 to 7 days in adults with normal thyroid function (how long it stays in your system)
- What the pharmacy pays
- ~$1.83 for 30 — not your price
- FDA application
- NDA215809
Foods & drinks to be careful with
Well-established interactions for this medicine’s drug class, summarized from public health authorities. General information, not medical advice — always confirm with your pharmacist or the label.
High-fibre foods and fibre supplements
Watch out for: beans, lentils, bran, whole grains, and psyllium or other fibre supplements — plus soybean flour and walnuts.
Fibre binds levothyroxine in the gut so less of it is absorbed. The Synthroid label names soybean flour, cottonseed meal, walnuts and dietary fibre as things that may bind and decrease absorption.
What to do: Keep taking the fibre — the fix is separation, not avoidance. Levothyroxine is taken on an empty stomach, and a consistent gap from high-fibre food and supplements matters more than the exact size of the gap. If you start or stop a fibre supplement, tell your prescriber: your dose may need re-checking.
Source: SYNTHROID (levothyroxine sodium) — FDA label, Drug Interactions (DailyMed)
How long does Levothyroxine Sodium stay in your body?
The elimination half-life of levothyroxine sodium is about 6 to 7 days in adults with normal thyroid function — the time it takes the body to clear about half of it. As a rule of thumb, a medicine is mostly gone after roughly 4 to 5 half-lives, though this varies from person to person with age and kidney or liver function. Half-life varies markedly with thyroid status: roughly 9 to 10 days in hypothyroidism (the condition being treated) and only 3 to 4 days in hyperthyroidism. This is the parent hormone (T4); its active product T3 has a shorter, not longer, half-life, so no longer-lived active metabolite applies.
This is general information, not medical advice. It doesn’t tell you when a drug test would read negative (tests detect substances for different, often longer, windows) or when it’s safe to take another dose — ask your pharmacist or prescriber. Source: SYNTHROID (levothyroxine sodium) tablets — DailyMed label.
Drug class
How this class works, per Levothyroxine - StatPearls - NCBI Bookshelf.
May treat (source: NIH RxClass)
See how Ermeza ranks — best-rated l-thyroxine for:
Dosage forms
Solution
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Ermeza treat?
- Ermeza (Levothyroxine Sodium) may be used to treat goiter, myxedema, thyroid neoplasms, autoimmune thyroiditis, thyrotoxicosis, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How does Ermeza work?
- Ermeza is a l-thyroxine. L-thyroxine is a synthetic copy of the thyroid hormone T4. It replaces the hormone an underactive thyroid can't make and is converted in the body to active T3, which enters cells to restore normal metabolism and energy levels.
- How is Ermeza rated?
- pharmaranks gives Ermeza a composite score of 3.3 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- How much does Ermeza cost?
- Nobody can tell you what you will pay — your price is set by your insurer's formulary, your deductible and the pharmacy's markup, and none of those are published. What IS published is what the pharmacy paid to acquire it: about $1.83 for 30, per the CMS NADAC survey. Treat that as the floor, not the quote — ask the pharmacist for the cash price as well as your copay, because for cheap generics the cash price often wins.
- Is there a coupon or discount for Ermeza?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Ermeza. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Ermeza?
- Ermeza is marketed by Mylan. You can see Mylan's full profile, rating, and other products on pharmaranks.
- Is Ermeza a brand-name or generic drug?
- Ermeza is a brand-name product with the active ingredient Levothyroxine Sodium. Lower-cost generic equivalents containing Levothyroxine Sodium are available — ask your pharmacist.
- Is Ermeza available over the counter?
- No. Ermeza is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Ermeza come in?
- Ermeza is currently marketed as solution, per the FDA's National Drug Code Directory.
- What class of drug is Ermeza?
- Ermeza is classified as l-thyroxine, per the FDA's Established Pharmacologic Class.
- Is Ermeza FDA-registered?
- Ermeza is on record with the U.S. FDA under application number NDA215809. You can verify this on its official FDA label.
- Has Ermeza been recalled by the FDA?
- Ermeza has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Ermeza safe?
- There's no single safe-or-not verdict. pharmaranks gives Ermeza a recall-safety score of 66/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
Reviews
No reviews yet. Be the first to write one.
People also viewed
synthroid
Levothyroxine Sodium
thyro-tabs
Levothyroxine Sodium
tirosint
Levothyroxine Sodium
tirosint-sol
Levothyroxine Sodium
levothyroxine sodium
Levothyroxine Sodium
levolet
Levothyroxine Sodium
Compare Ermeza head-to-head
More l-thyroxine drugs
Guides for this medication
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
ermeza
66/100